Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Yinan  [Clear All Filters]
2023
Li Y, Smith JJ, Marques F, Osuma A, Huang H-C, Kratsios P. Cell context-dependent CFI-1/ARID3 functions control neuronal terminal differentiation. Cell Rep. 2023;42(3):112220.
Chen L, Liu Y, Wang Z, Zhang L, Xu Y, Li Y, Zhang L, Wang G, Yang S, Xue G. Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosis. Exp Mol Med. 2023.
2022
Wei Y, Chen Q, Huang S, Liu Y, Li Y, Xing Y, Shi D, Xu W, Liu W, Ji Z, et al. The Interaction between DNMT1 and High-Mannose CD133 Maintains the Slow-Cycling State and Tumorigenic Potential of Glioma Stem Cell. Adv Sci (Weinh). 2022:e2202216.
2020
Lovnicki JM, Gan Y, Feng T, Li Y, Xie N, Ho C-H, Lee AR, Chen X, Nappi L, Han B, et al. LIN28B promotes the development of neuroendocrine prostate cancer. J Clin Invest. 2020.
2019
Wang Z, Liu W, Wang C, Li Y, Ai Z. Acetylcholine promotes the self-renewal and immune escape of CD133+ thyroid cancer cells through activation of CD133-Akt pathway. Cancer Lett. 2019.
Wei Y, Shi D, Liang Z, Liu Y, Li Y, Xing Y, Liu W, Ai Z, Zhuang J, Chen X, et al. IL-17A Secreted from Lymphatic Endothelial Cells Promotes Tumorigenesis by Up-regulation of PD-L1 in Hepatoma Stem Cells. J Hepatol. 2019.
Cao B, Duan M, Xing Y, Liu C, Yang F, Li Y, Yang T, Wei Y, Gao Q, Jiang J. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E. J Cell Mol Med. 2019.
2015
Liu Y, Ren S, Xie L, Cui C, Xing Y, Liu C, Cao B, Yang F, Li Y, Chen X, et al. Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth. Oncotarget. 2015.